Montelukast Prescribing at SPRING-FENISCO HEALTHLINK
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
390
Total Quantity
12.6K
NHS Cost
£632
vs National Avg
-43%
SPRING-FENISCO HEALTHLINK prescribed 390 items of Montelukast over the last 12 months at a cost of £632 to the NHS. This is 43% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
32
Jul 2026
26
Jul 2026
32
Jul 2026
28
Jul 2026
27
Jul 2026
34
Jul 2026
30
Jul 2026
33
Jul 2026
37
Jul 2026
38
Jul 2026
32
Jul 2026
41
Prescribing Details
| Total Items | 390 |
|---|---|
| Total Quantity | 12,642 |
| Total NHS Cost | £632 |
| Presentations | 4 different forms |
| vs National Average | -43% |
Montelukast Prescribing Comparison
| This practice | 390 items |
|---|---|
| National average per practice | 685 items |
| Difference | -43% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.